MedPath

Assessment of the impact of national breast cancer screening program in achieving downstaging of breast cancer and improving quality of life of breast cancer patients in Morocco

Not Applicable
Completed
Conditions
Breast cancer
Cancer
Malignant neoplasm of breast
Registration Number
ISRCTN16276576
Lead Sponsor
International Agency For Research On Cancer
Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38837217/ (added 11/07/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
1081
Inclusion Criteria

Women registered with the histopathology diagnosis of breast cancer at the designated cancer centre(s) during the study period

Exclusion Criteria

Women in whom the final histopathology diagnosis will be benign disease; recurrent breast cancers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath